MSB 9.41% $1.61 mesoblast limited

BLA resubmission for children with SR-aGVHD, page-27

  1. 3,987 Posts.
    lightbulb Created with Sketch. 374
    Australia’s Mesoblast submits final module of rolling BLA submission for pediatric GVHD stem cell therapyFeb. 4, 2020
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
-0.168(9.41%)
Mkt cap ! $1.909B
Open High Low Value Volume
$1.72 $1.74 $1.58 $7.821M 4.734M

Buyers (Bids)

No. Vol. Price($)
14 16542 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.62 10081 7
View Market Depth
Last trade - 12.37pm 15/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.